ABSTRACT
Mucormycosis is an emerging fungal infection with extremely high mortality rates in patients with defects in their innate immune response, specifically in functions mediated through phagocytes. However, we currently have a limited understanding of the molecular and cellular interactions between these innate immune effectors and mucormycete spores during the early immune response. Here, the early events of innate immune recruitment in response to infection by Mucor circinelloides spores are modeled by a combined in silico modeling approach and real-time in vivo microscopy. Phagocytes are rapidly recruited to the site of infection in a zebrafish larval model of mucormycosis. This robust early recruitment protects from disease onset in vivo. In silico analysis identified that protection is dependent on the number of phagocytes at the infection site, but not the speed of recruitment. The mathematical model highlights the role of proinflammatory signals for phagocyte recruitment and the importance of inhibition of spore germination for protection from active fungal disease. These in silico data are supported by an in vivo lack of fungal spore killing and lack of reactive oxygen burst, which together result in latent fungal infection. During this latent stage of infection, spores are controlled in innate granulomas in vivo. Disease can be reactivated by immunosuppression. Together, these data represent the first in vivo real-time analysis of innate granuloma formation during the early stages of a fungal infection. The results highlight a potential latent stage during mucormycosis that should urgently be considered for clinical management of patients.
KEYWORDS: fungal infection, fungal pathogenesis, host-pathogen interactions, innate immunity, macrophages, mathematical modeling, mucormycosis, neutrophils, phagocytes, zebrafish
IMPORTANCE
Mucormycosis is a dramatic fungal infection frequently leading to the death of patients. We know little about the immune response to the fungus causing this infection, although evidence points toward defects in early immune events after infection. Here, we dissect this early immune response to infectious fungal spores. We show that specialized white blood cells (phagocytes) rapidly respond to these spores and accumulate around the fungus. However, we demonstrate that the mechanisms that enable phagocytes to kill the fungus fail, allowing for survival of spores. Instead a cluster of phagocytes resembling an early granuloma is formed around spores to control the latent infection. This study is the first detailed analysis of early granuloma formation during a fungal infection highlighting a latent stage that needs to be considered for clinical management of patients.
INTRODUCTION
Mucormycosis is the second most common fungal mold infection and is associated with extremely high mortality (up to >90% in disseminated infection) (1). Disease is caused by a spectrum of species belonging to the Mucorales (e.g., Rhizopus oryzae, Mucor circinelloides, and Lichtheimia corymbifera). Symptoms are due to spore germination and filamentous fungal growth within the host leading to angioinvasion, vessel thrombosis, and tissue necrosis (2–4). Although little epidemiological data is available for mucormycosis, estimates suggest approximately 10,000 infections are due to Rhizopus oryzae annually (5, 6). Individuals with hematopoietic disorders or transplants are particularly at risk of disease, with 8 and 16% of patients, respectively, presenting with mucormycosis (5). Mucormycosis is considered an emerging disease, with reported 7.3 and 9.3% increases in incidence and mortality between 2001 and 2010, respectively (7). Treatment of mucormycosis is very costly, with an average expense of $100,000 per case, and remains unsuccessful in most cases (8). Current antifungal therapy for mucormycosis is ineffective, and treatment involves extensive surgical removal of infected tissue, often leading to limb amputation and long-term disability. Therefore, there is clearly a clinical need for a more effective treatment strategy.
Mucorales are opportunistic pathogens. Thus, understanding how the immune system naturally prevents pathological disease and identifying the crucial components may inform future targets for mucormycosis therapy. Susceptible patients often present with innate immune defects (for example, neutropenia and impaired macrophage or neutrophil functions) due to uncontrolled diabetes or corticosteroid therapy (1, 5, 9, 10). This highlights the essential role of phagocytes for an effective immune response to mucormycosis. To counteract the immune response, there is strong evidence for an immune-inhibitory effect of infectious fungal spores (11, 12).
Traditional animal models to study the pathogenesis of mucormycosis have been limited and do not allow for the integrative study of cellular interactions (13). Host expression studies of R. oryzae infections in the fruit fly (Drosophila melanogaster) infection model showed downregulation of genes in several pathways, including pathogen recognition, immune defense, and stress responses (14). Murine bronchoalveolar macrophages inhibit germination of R. oryzae spores and thus prevent formation of invasive hyphal forms in the healthy host (11, 12, 15, 16). However, macrophages and neutrophils are unable to kill fungal spores (11, 12, 17). In addition, macrophages from diabetic or corticosteroid-treated mice fail to inhibit spore germination (15, 18). Despite this, the molecular and cellular interactions during the early immune response to mucormycete spores are poorly understood. Yet, this information may offer an immunomodulatory target for protection from disease onset. Using our in vivo larval zebrafish (Danio rerio) model of mucormycosis, we previously demonstrated that macrophages and neutrophils are rapidly recruited to the site of infection with M. circinelloides (17).
In this study, we model the early events of innate immune recruitment in response to M. circinelloides spores by a combined in silico modeling and real-time microscopy approach in vivo. Utilizing our recently established zebrafish infection model (17), we took advantage of the optical transparency of zebrafish larvae, which allow for real-time microscopy, to model the early temporal-spatial events of innate immune recruitment in response to fungal spores in vivo. We combined this experimental analysis with mathematical modeling to identify the essential parameters for protection from pathological disease. We showed that robust early phagocyte recruitment is crucial for protection from disease. Proinflammatory cytokine signals (e.g., early transcription response of the tnf-α and and il-8 genes, coding for tumor necrosis factor alpha [TNF-α] and interleukin-8 [IL-8], respectively) are important for induction of effective phagocyte recruitment. Yet, our data suggest that protection is dependent on the capacity, rather than the rate, of phagocyte recruitment to the site of infection. At the site of infection, phagocytes form tight clusters around spores resembling early granulomas. While spores are successfully contained in these early granulomas, which we term innate granulomas, we observe a lack of reactive oxygen burst and failure to kill fungal spores. Moreover, disease can be reactivated by dexamethasone (Dex)-induced immunosuppression. Together, this is the first real-time analysis of innate granuloma formation during the early stages of a fungal infection. Our data indicate the potential for a latent infectious stage during mucormycosis that needs to be considered for clinical management of patients.
RESULTS
Phagocytes are rapidly recruited to the site of Mucor circinelloides infection in vivo.
Zebrafish larvae do not have an adaptive immune system and rely on their innate immune cells to respond to infectious stimuli. We took advantage of this characteristic to define the phagocyte response to infection with M. circinelloides asexual spores. We used transgenic zebrafish larvae with fluorescently tagged macrophages [Tg(mpeg1:G/U:NfsB-mCherry)] and neutrophils [Tg(mpx:GFP)] to assess whole-larval phagocyte number. Phagocyte recruitment was observed by fluorescence microscopy in uninjected larvae or after microinjection of control medium (polyvinylpyrrolidone [PVP]) or 100 M. circinelloides spores in the hindbrain ventricle of 36-h-old zebrafish larvae (Fig. 1A). Phagocyte numbers were counted before microinjection and every 24 h after injection. Both macrophage and neutrophil numbers increased with larval age, even in untreated larvae (Fig. 1B and C). However, the total numbers of macrophages (P < 0.001, two-way analysis of variance [ANOVA]) and neutrophils (P < 0.001, two-way ANOVA) in the whole larvae increased 11.2- and 5.6-fold, respectively, following spore injection compared to 5.0- and 3.2-fold increases, respectively, in control-injected larvae (Fig. 1B and C). This suggested a global innate immune response to M. circinelloides infection in this model system.
Next, we wanted to understand how this global increase in phagocyte numbers correlates to phagocyte recruitment to the site of infection. We previously conducted real-time imaging to qualitatively illustrate that phagocytes are recruited in response to M. circinelloides spores in our in vivo zebrafish larval hindbrain ventricle model (17). Here, we analyzed these movies quantitatively by high-resolution tracking of phagocyte movement from the whole fish toward infectious fungal spores at the site of infection using the software Volocity. Data were analyzed for the first 14 h postinfection (hpi). Mean fluorescence intensity (MFI) for mCherry-tagged macrophages and green fluorescent protein (GFP)-tagged neutrophils was measured at the site of infection in transgenic zebrafish larvae. Infected larvae exhibit rapid onset of macrophage recruitment to the site of infection with live spores. The number of macrophages steadily increased until maximum recruitment was achieved 12 hpi (Fig. 1D). Macrophage recruitment in response to infection with dead spores was 2.1-fold lower (P < 0.0001, analysis of covariance) (Fig. 1D). Onset of neutrophil recruitment was delayed until 4 hpi, after which neutrophil recruitment proceeded until 9 hpi, when maximum recruitment was reached (Fig. 1E). There were 3.0-fold fewer neutrophils recruited to the site of infection in response to dead spores compared to injection with live spores (P < 0.0001, analysis of covariance) (Fig. 1E).
Collectively, these data show that zebrafish respond rapidly to infection with live M. circinelloides spores both by increasing their phagocyte number and by recruiting phagocytes to the site of infection.
Robust early phagocyte recruitment protects from Mucor circinelloides in vivo.
Immunosuppression predisposes individuals to mucormycosis. However, the mechanism for this enhanced susceptibility is not fully understood. We employed dexamethasone (40 μg/ml), a well-established corticosteroid that mimics immune inhibition in the context of mucormycosis (17, 19, 20), to analyze the impact on phagocyte recruitment after infection with mucormycete spores. Our zebrafish model lacks a fully functional adaptive immune system. In this context, dexamethasone’s immune-inhibitory effects would most likely affect the innate immune response by inhibiting proinflammatory mechanisms.
Dexamethasone-treated larvae infected in the hindbrain ventricle exhibited significantly increased mortality relative to untreated larvae (67.2% versus 36.1%; P < 0.0001, Mantel-Cox log-rank test) (Fig. 2A). This difference is most visible 96 hpi, mostly likely due the invasive fungal growth having reached the critical threshold leading to host death. At the same time, dexamethasone treatment significantly reduced the numbers of macrophages (1.7-fold; P < 0.0001, Mann-Whitney U test) and neutrophils (1.5-fold; P < 0.0001, Mann-Whitney U test) recruited to the site of infection 24 hpi (Fig. 2B and C). We followed the fate of these larvae and recorded the time of larval death. There was a strong correlation between the numbers of macrophages (P < 0.0001, Pearson correlation) and neutrophils (P < 0.0001, Pearson correlation) and the time of mortality (Fig. 2D and E). While macrophage and neutrophil numbers were significantly reduced at the site of infection after dexamethasone treatment, the corticosteroid did not alter overall phagocyte numbers (whole body) or inhibit the global increase in phagocyte numbers in response to the infectious stimulus (see Fig. S1 in the supplemental material). Whole-larval phagocytes also outnumbered recruited phagocytes, indicating that recruitment was not limited by phagocyte availability (Fig. 1B and C and 2B and C; Fig. S1).
Taken together, these data suggest that phagocyte recruitment to the site of infection is an essential aspect in the prevention of morbidity and mortality. Moreover, phagocyte numbers recruited to the site of infection 24 hpi may have predictive value for disease progression and/or outcome.
The importance of phagocyte recruitment for protection from Mucor circinelloides can be modeled by an in silico approach.
Our experimental data demonstrate that whole-fish phagocyte count does not predict outcome. Rather, local phagocyte numbers at the site of infection affect infection outcome. To investigate this further, we took a mathematical modeling approach to perturb parameters affecting the system of interest, either individually or in combination. Such an investigation is relatively straightforward compared to its experimental equivalent and can yield vital insight into a system and help to guide future experimental work. We therefore modeled infection dynamics using the schematic presented in Fig. 3A and B. We thus present results for this model based on three categories of zebrafish, each distinguished by their maximum phagocyte number at the infection site (carrying capacity): an “immunocompromised” zebrafish (maximum macrophage number KM = 5, maximum neutrophil number KN = 5), a “susceptible” zebrafish (KM = KN = 12), and a “healthy” zebrafish (KM = KN = 20). Our experimental observations showed that if an infected zebrafish survived until after 96 h postinfection (here denoted as 120-h survival), it was likely to survive the infection entirely. We thus demark 120 h as a survival point if the number of hyphae has not yet passed the critical threshold, H*.
We simulated variations in all individual model parameters (Fig. 3A and B) (within what might be considered a reasonable range) bar KH (which was not deemed to be an aspect of the system that could be manipulated in practice), while fixing the other parameters at their default values (with phagocyte carrying capacities as given above) and recorded the change in predicted survival time (Fig. 3C to E). In agreement with the experimental findings that phagocyte number at the site of infection (carrying capacity) is crucial in influencing disease outcome, the ability to support survival by varying any one of the parameters was highly dependent upon the maximum number of phagocytes at the infection site. For the “immunocompromised” zebrafish (low KM, KN), only a decrease in rH (germination rate) or a large increase in KM (macrophage carrying capacity) changed survival outcome (Fig. 3C). In contrast, survival could be supported in the “susceptible” zebrafish (intermediate KM, KN) by varying any individual parameter within the range tested (Fig. 3D). Notably, in these zebrafish simulations, relatively small increases to parameters associated with the macrophage response (particularly KM) were sufficient to support survival. While altering the phagocyte recruitment rates (rM, rN) could also support survival, a large fold increase was required for these parameters: i.e., the effectiveness of the immune response may be more sensitive to changes in the maximum number of macrophages present at the infection site than it is to the speed at which these immune cells can arrive at the infection site. The “healthy” zebrafish (large KM, KN) could, to an extent, cope with worsened parameter values (e.g., KN = 0) and still survive (Fig. 3E).
Thus, our mathematical model can predict our experimental data that sufficient phagocyte recruitment to the site of infection is essential for protection from mucormycosis.
In silico modeling indicates that protection from Mucor circinelloides is dependent on maximum phagocyte number at the site of infection.
The variation between our three categories of zebrafish suggests that maximum phagocyte numbers at the infection site (particularly KM) are not only a critical factor to survival, but are capable of influencing the effect of varying the other parameters on survival time: i.e., the sensitivity of the immune response to the other parameters varies depending on the value of KM. To examine this phenomenon further, we varied KM and each other parameter simultaneously and examined the impact on survival time. We illustrate only those results for the “susceptible” zebrafish (Fig. 4). Most striking is that, for survival, some parameters are dispensable with a sufficiently high KM. There were minimum thresholds required for those parameters associated with macrophage function: i.e., nonzero rM and βM are needed for survival. (The first of these is intuitive since macrophage arrival at the infection site is also required for the secondary neutrophil response.) By varying rM and KM simultaneously, we see that having a small number of macrophages arrive quickly at the infection site is likely to be less influential than having large numbers arrive more slowly. For sufficiently high rH, death was always predicted before 120 h regardless of KM (in the range tested). Since macrophages are assumed to be required for neutrophil recruitment, in no case could the infection be survived if KM = 0. Given the dominance of KM in these simulations, equivalent results for the “immunocompromised” zebrafish are highly similar despite a lower KN value (see Fig. S2 in the supplemental material).
Taken together, our mathematical model highlights the maximum number of phagocytes at the site of infection as the critical factor for host survival.
In silico modeling indicates the role of proinflammatory signals for phagocyte recruitment and highlights the role of inhibition of spore germination for protection from active mucormycosis.
Together, our experimental and in silico data suggest that the presence of phagocytic cells at the site of infection, rather than the rate at which the pool of available phagocytic cells arrive, is a crucial determinant of disease outcome. Proinflammatory cytokines are well-known stimuli that sequester the recruitment of immune cells. Patients with reduced proinflammatory capacity due to medical interventions such as corticosteroid treatment have higher risk of mucormycosis (3, 5, 21). We thus assessed the impact of proinflammatory cytokine expression on effective phagocyte recruitment. We modeled a series of time-dependent simulations representing various proinflammatory responses and examined their effects on mucormycosis outcome. We tested the impact of the rates of phagocyte recruitment (rM and rN), the inhibitory function of phagocytes (βM and βN), the carrying capacities of the phagocytes (KM and KN), and the rate of fungal germination (rH). Assuming there would be a limitation on how much these rates could be altered in reality, relatively small changes to parameters were used, doubling or halving as appropriate, with the exception of KM and KN, which were allowed to vary up to a total number of 50 (as observed in experiments). We also mimicked a proinflammatory response, whereby in silico phagocytes could directly clear spores and hyphae (see Fig. 5 for details of the model alteration). The above responses were applied to the parameter sets for “susceptible” (KM = KN = 12) and “immunocompromised” (KM = KN = 5) zebrafish, with an aim to facilitate survival (defined to occur if H < H* for all times t ≤ 120 h). Two different profiles were required to protect either the “immunocompromised” or the “susceptible” zebrafish. First, the “susceptible” zebrafish was receptive to a variety of perturbations (Fig. 5A). The most efficacious strategies to protect from onset of active mucormycosis were by directly inhibiting the rate of hyphae formation (rH), doubling the ability of immune cells to inhibit hyphae formation (βN, βM), or increasing the numbers of macrophages (KM) and neutrophils (KN). The last of these, which provides the zebrafish with more phagocytes or neutrophils at the infection site than the previously defined baseline “healthy” zebrafish, achieved the lowest hyphae number over the 120-h time course, in line with the importance of phagocyte carrying capacity in protecting from disease. An increase to only KM, KN = 14 (i.e., fewer than the “healthy” zebrafish) also predicted survival until 120 h, but with formation of more hyphae (results not shown), indicating a threshold number for partial control. In addition, direct killing of spores and hyphae by phagocytes was predicted as a successful strategy to support survival, with δ1, δ2 = 0.03 (where δ1 and δ2 are the maximum rates of spore and hyphae killing, respectively). In contrast, the three most effective strategies for the “susceptible” zebrafish were the only three modifications that conferred protection on the “immunocompromised” zebrafish: an increase in maximum phagocyte number at the infection site (equivalent simulation to the “susceptible” zebrafish); direct killing of spores and hyphae by phagocytes, although this needed to be at a 2-fold higher rate than for the “susceptible” zebrafish (δ1, δ2 = 0.06); or a 3-fold decrease in the germination rate (rH) (as opposed to a 2-fold decrease for the “susceptible” zebrafish) (Fig. 5B).
FIG 5 .
Given the fast progression of mucormycosis and rapid hyphal growth under immunosuppressed conditions, we tested the relative contributions of phagocyte carrying capacity and inhibition of spore germination to disease establishment. Two scenarios were used: first, macrophage carrying capacities were increased by a relatively small amount to KM, KN = 8 (Fig. 5C); second, in addition to this increase in carrying capacity, macrophage function (germination inhibition coefficients βM and βN) was doubled (Fig. 5D). Neither of these approaches in isolation was capable of ensuring the zebrafish survive the infection under this parameter set. We then combined both scenarios with alterations to the following responses postinfection: (i) halving the hyphae formation rate, rH; (ii) phagocyte-induced killing of hyphae and spores introduced (δ1, δ2 = 0.03); or (iii) both of the preceding. Inhibition of hyphae formation in combination with the increased macrophage carrying capacity was protective against mucormycosis (Fig. 5C, combination 1a), while phagocytic killing at the simulated rate did not sufficiently inhibit hyphal growth, even at these enhanced macrophage levels (Fig. 5C, combination 2a). Under our parameter set, an increase in phagocytic killing is only protective under increased germination-inhibiting potential (Fig. 5C, combination 3a). Increasing both phagocyte numbers and function (i.e., germination inhibition coefficients) proved to be the most effective at restricting hyphal number (compare Fig. 5C and D).
Together, these in silico data suggest that a single proinflammatory response alone (i.e., phagocytic recruitment or killing) may be insufficient to prevent hyphal growth and protect against fulminant mucormycosis in immunocompromised hosts.
Phagocytes control Mucor circinelloides spores in innate granulomas in vivo.
Our model indicates several protective mechanisms that would support mucormycosis management. We therefore tested a range of these predictions.
First, our model indicates that proinflammatory signals are essential for the recruitment of phagocytes. Thus, we here assessed the early (1 hpi) transcriptional response of the proinflammatory cytokine gene tnf-α and the chemotactic cytokine gene il-8 in control- and dexamethasone-treated fish. We observed a significant transcriptional upregulation for both cytokines (tnf-α, 4.1-fold; il-8, 1.9-fold) in spore-injected larvae compared to mock-injected (PVP) larvae (P < 0.05 [n = 6], Mann-Whitney U test) (Fig. 6A and B). After dexamethasone treatment, the transcriptional response for both proinflammatory cytokines after spore injection was reduced compared to mock-injected fish (tnf-α, 0.6-fold; il-8, 0.3-fold) and significantly lower than in untreated fish (Fig. 6A and B) (P < 0.01 [n = 6], Mann-Whitney U test). These data are in agreement with our mathematical modeling results.
Second, our model indicates spore killing by phagocytes would be an effective protective response to infection. However, we had previously shown that spores remain viable inside the zebrafish for 48 hpi, despite rapid and robust recruitment of phagocytes to the site of infection (17). We now extended our assessment of spore viability to 96 hpi, demonstrating that there is no reduction in spore viability upon infection, even after contact with phagocytes for 96 h (Fig. 6C) (P = 0.229 [n = 5], Kruskal-Wallis test). This indicates a lack of antimicrobial activity by these recruited phagocytes. The induction of reactive oxygen species (ROS) is a well-known phagocytic mechanism to achieve microbial killing (15, 22–25). Thus, we measured the ROS production in response to fungal spores in the whole zebrafish embryo. In comparison to an ROS-inducing stimulus that generates ROS levels similar to those enabling Candida albicans killing by neutrophils (26), infection with spores stimulated significantly lower ROS levels (P < 0.0001 [n = 9], Mann-Whitney U test) (Fig. 6D).
Together, these data raise the question as to how M. circinelloides is controlled in zebrafish larvae. We have previously demonstrated that, upon infection, a dense phagocyte cluster forms around the spores (17) (Fig. 6E). We have termed this cluster an innate granuloma. Similar innate granulomas have been described in the zebrafish larval model for Mycobacterium tuberculosis, a bacterium that is contained in granulomas (27). Our in silico data predict that innate granuloma formation, which localizes phagocytic cells to the site of infection, is important for disease control. Therefore, to test in vivo if the formation of innate granulomas in response to infection with M. circinelloides spores is required to control the fungal infection, we immunosuppressed larvae with dexamethasone and monitored innate granuloma formation, hyphal formation, and spore dissemination. The formation of innate granulomas was significantly reduced in immunosuppressed zebrafish (P < 0.0001 [n = 61], Fisher’s exact test) (Fig. 6F), while at the same time hyphal formation was significantly increased (P < 0.0001 [n = 61], Fisher’s exact test) (Fig. 6F), and there was an overall trend of increasing spore dissemination (Fig. 6F).
In summary, our data demonstrate the importance of phagocyte carrying capacity at the site of infection (Fig. 3 and 4), a lack of spore killing (Fig. 6C), and an increase of larval mortality with lack of phagocyte recruitment to the site of infection (Fig. 2). Together with our previously reported data demonstrating the lack of phagocyte cluster formation after injection with dead spores (17), we propose a model in which M. circinelloides spores establish latent infections in the host. The host in turn contains the spores in innate granulomas, a mechanism to achieve full carrying capacity at the site of infection, to control the fungal infection.
Latent infection with Mucor circinelloides can be activated out of innate granulomas by immunosuppression in vivo.
Our in vivo spore killing and ROS data suggest that innate granulomas control, but do not clear, fungal spores. To test our hypothesis that latent fungal infections are controlled, but not cleared, by innate granulomas in vivo, we reactivated fungal disease by immunosuppression with dexamethasone after formation of innate granulomas. Zebrafish larvae were injected with spores and screened for innate granuloma formation 24 hpi. Innate granuloma-positive larvae were then submerged in dexamethasone-containing growth medium and monitored for survival and by microscopy. Immunosuppression led to rapid mortality that was significantly higher (92.5%) than that in untreated, infected larvae (15.4%) (Fig. 7A) (P < 0.0001, Mantel-Cox log-rank test). It is noteworthy that control larvae exhibiting innate granuloma formation also showed a reduced mortality compared to nonselected untreated larvae (which included larvae with and without granulomas), which had an overall mortality of 36.1% (Fig. 2A) (P = 0.01, Mantel-Cox log-rank test). This suggests some variability within the larval population that might lead to increased susceptibility in some individuals. Microscopic examination revealed that within as little as 3 h of treatment, innate granulomas failed to suppress spore germination and filamentous growth (Fig. 7B), leading to complete fungal invasion and consumption of the larvae after 48 h (Fig. 7C).
Together, these data support a model in which initial recruitment of phagocytic cells to the site of infection supports granuloma formation, thereby ensuring high local phagocyte number (KM, KN). Innate granulomas are sufficient to control, but not clear, the infection, and loss in maximum phagocyte number either prior to infection or after granuloma formation leads to fulminant mucormycosis and mortality.
DISCUSSION
We here present a study investigating the temporal-spatial pattern of innate immunity during mucormycosis. We model the early events of innate immune recruitment in response to M. circinelloides spores by a combined real-time in vivo microscopy and in silico modeling approach. In view of our data, we propose that infection with mucormycetes is controlled by innate granulomas, while at the same time inducing a latent stage of infection during mucormycosis that can be reactivated by immunosuppression. This is an expansion of our initial observation that phagocytes accumulate at the site of infection and that failure to do so correlates with spores being disseminated from the site of infection. Specifically, we provide a detailed timeline for innate granuloma formation and show that immunosuppression with dexamethasone reduces innate granuloma formation. We also give insights into how spores maintain latency within innate granulomas by reducing ROS and proinflammatory signals. Lastly, we demonstrate that infection can be activated from a latent stage.
Granulomatous structures have been described in histopathological examinations for a large spectrum of opportunistic fungal infections (e.g., cryptococcosis, mucormycosis, candidiasis, and chromoblastomycosis) (28–30). However, granulomas are best studied in the context of infections with Mycobacterium tuberculosis, the causative agent of tuberculosis (TB). Macrophages and neutrophils can control TB by slowing down bacterial growth during early infection, yet also function as vehicles for later tissue dissemination (31, 32). Granuloma formation during TB may provide both a means to control infection and also a niche for bacteria to survive, waiting for an opportunity to break out and cause disease. It is well documented that several fungal pathogens can survive within individual macrophages or neutrophils (e.g., Cryptococcus neoformans [33], Candida albicans [34], and mucormycetes [35]) (Fig. 6C), dissemination in phagocytes as trafficking vehicles has been proposed for Cryptococcus neoformans (36), and immune-inhibitory effects of infectious mucormycete spores on the innate immune system have been reported (11, 12). To survive within a healthy host, pathogens need to overcome the phagocytic antimicrobial machinery. It is currently not clear whether granuloma forms due to failure to kill a pathogen (host induced) or whether failure to kill the bacteria is a result of granuloma formation and thus might be pathogen induced. While innate granuloma formation during infections with opportunistic M. circinelloides spores appears to have a protective role for the host by controlling infectious particles, granulomas might also offer a protective niche for delayed disease activation (Fig. 7). Our zebrafish infection model offers an ideal system to fully investigate this.
Mucormycetes are emerging pathogens, with extremely high mortality rates of over 95% in those with disseminated disease (37, 38). This is due to an increase in susceptible individuals, a current lack of therapeutic antifungal interventions, and a current lack of understanding of mucormycosis pathogenesis. Mucormycosis is a suite of diseases caused by a range of opportunistic pathogens, which indicates that healthy individuals can effectively control the infection. Patients that present with mucormycosis commonly show impaired function of effector cells of the innate immune system: i.e., macrophages and neutrophils (1, 5, 9, 10). Thus, an improved understanding of the mechanisms that enable fungal control in healthy individuals will expand our understanding of mucormycosis in susceptible patients and may inform treatment strategies.
In this study, we dissected the in vivo real-time dynamics of the innate immune response (Fig. 1) in a zebrafish larval model of mucormycosis (17). We demonstrate that zebrafish larvae initiate a global innate response to fungal spores by increasing their phagocyte population (Fig. 1B and C) and rapidly recruit phagocytes to the site of infection (Fig. 1D and E). This robust early phagocyte recruitment to the site of infection provides protection from disease onset (Fig. 2). In silico mathematical modeling enabled us to dissect the parameters of the recruitment response conferring protection. Interestingly, protection appears to be dependent on the number of phagocytes (carrying capacity) at the infection site and less so on the speed of recruitment (Fig. 3). These data expand on previous reports showing that in healthy hosts, phagocytes are recruited to the site of infection and internalize spores in vertebrate models (4, 17, 39–42), thus offering a mechanistic explanation of how this response is disrupted in susceptible hosts (15, 17, 40) (Fig. 2).
Our computational modeling emphasized the importance of macrophage number on disease outcome and predicts which proinflammatory responses may be lacking in zebrafish who do not survive mucormycosis infection (Fig. 5). Ultimately, combining such in silico modeling with experimental work should accelerate progress toward the development of therapies to tackle mucormycosis and related infections. Importantly, our data highlight the critical role of prophylactic or early infection control, presenting a major challenge to controlling mucormycosis in the clinic. One therapeutic option would be to support the recruitment of macrophages (rM) and neutrophils (rN) during the initial phases of infection. While infection may be difficult to predict in a clinical setting, the early administration times required in our model simulations for protection against infection are relative to the predicted time of death in the zebrafish larvae, which when untreated, is around 40 h (Fig. 5B). In patients, mortality occurs within a much more variable time frame ranging from days to months, providing a longer working window for successful treatment.
In a clinical setting, a treatment that can be successfully delivered even in the late stages of an infection is most desirable. While phagocytes fail to kill spores (Fig. 5C), they can prevent the germination of spores in vivo (15, 18, 43). In susceptible hosts, inhibition of spore germination fails, leading to filamentous growth (15, 18). Our mathematical model further highlights the importance of inhibiting spore germination for protection from active fungal disease. Inhibition of hyphal formation either directly or via immune cell recruitment proved efficacious and may be a plausible control method within a helpful time period (Fig. 6B). Combinations of proinflammatory responses may be capable of facilitating survival in even severely immunocompromised individuals (Fig. 6).
We demonstrate in vivo lack of mucormycete spore killing and lack of reactive oxygen burst, which together potentially result in latent fungal infection (Fig. 5C and D). During this latent stage of infection, spores are controlled in innate granulomas in vivo and disease can be reactivated by immunosuppression. Unlike TB and other diseases classically associated with granuloma formation, mucormycosis is not associated with T-cell deficiencies, indicating that adaptive immunity has a secondary role in the immune response to mucormycete infection (44). Our model host does not have a developed adaptive immune system and thus relies on innate immune effectors to respond to infectious stimuli, allowing specific dissection of the innate immune response to infections. However, we note that T-cell responses are activated in the context of human disease (45, 46) and might be involved in spore clearance.
Taken together, this is the first real-time analysis of innate granuloma formation during the early stages of a fungal infection. We have presented a novel interdisciplinary strategy to understanding the interplay between the host immune response and mucormycetes. Recent work has shown that spores induce proinflammatory responses upon encountering macrophages (17, 47). Our data suggested that proinflammatory signals are beneficial in controlling mucormycosis by inducing phagocyte recruitment, and both phagocyte number and activity were found to be required for protection from disease onset. While direct phagocyte-mediated fungal killing would be promising as a protective measure from mucormycosis in silico, our experimental results showed that phagocytes fail to mount an effective antimicrobial response to spores. We observed a lack of reactive oxygen burst and failure to kill fungal spores in vivo. Instead, protection is mediated by robust phagocyte recruitment by innate immune effectors, which drive the formation of early innate granulomas. While spores are successfully contained in these early granulomas (innate granulomas), disease can be reactivated by dexamethasone-induced immunosuppression, indicating the potential for a latent infectious stage during mucormycosis that needs to be considered for clinical management of patients. While frequently observed during fungal infections, the role of granulomas in fungal disease pathogenesis and latency has been overlooked to date. A better understanding of the role of fungal granulomas in latency during fungal infections has the potential to significantly improve our clinical management of patients by enabling the identification of individuals at risk of disease and thus informing the need for prophylactic strategies either directly by targeting the fungal pathogen or indirectly by immunomodulatory interventions.
MATERIALS AND METHODS
Mucor circinelloides strain and growth conditions.
NRRL3631, a clinical isolate of Mucor circinelloides, was used in this study (35). The fungus was grown at a density of 1,000 spores per 10-cm agar plate on Sabouraud dextrose (SAB) agar (pH 5.6) containing 0.5% (wt/vol) peptone from casein, 0.5% (wt/vol) peptone from meat, 4% (wt/vol) d(+)-glucose and 1.5% (wt/vol) agar (Merck Millipore, Watford, United Kingdom) in the dark at room temperature (17).
Zebrafish care and maintenance.
Adult zebrafish were kept in recirculating systems (ZebTec Active Blue zebrafish housing system; Tecniplast, London, United Kingdom) at the University of Birmingham’s zebrafish facility under a 14- to 10-h light-dark cycle and water temperature maintained at 28°C. All zebrafish care and experiments were conducted according to Home Office legislation and the Animals (Scientific Procedures) Act 1986 (ASPA) under Home Office project license 40/3681 and personal licenses l13220C2C to Kerstin Voelz and l9EE992EF to Aleksandra Jasiulewicz. Zebrafish eggs were obtained by natural mating. Eggs were collected, and 25 eggs were kept in 25 ml of E3 medium plus 0.00003% methylene blue (Sigma-Aldrich, Irvine, United Kingdom) and 26.6 μg/ml phenylthiourea (PTU; Sigma-Aldrich, Irvine, United Kingdom) at 32°C and under a 14- to 10-h light-dark cycle thereafter. Medium was changed every 2 days up to 5 days postfertilization (dpf). This study utilized wild-type AB zebrafish as well as transgenic zebrafish Tg(mpx:GFP)i114 expressing green fluorescent protein in neutrophils (48), Tg(mpeg1:Gal4-FF)gl25 (49) crossed with Tg(UAS-E1b:NfsB.mCherry)c264 [herein referred to as Tg(mpeg1:G/U:NfsB-mCherry)] with macrophage-specific expression of red fluorescent protein mCherry and nitroreductase, and Tg(mpeg1:G/U:NfsB-mCherry) crossed with Tg(mpx:GFP) [herein referred to as Tg(mpeg1:G/U:NfsB-mCherry/mpx:GFP)] with neutrophil-specific expression of green fluorescent protein and macrophage-specific expression of red fluorescent protein mCherry. All zebrafish care and husbandry procedures were performed as previously described, and larvae were observed throughout the experimental procedures for normal anatomical development (17, 50).
Spore preparation for injection.
Prior to injections, sporangiospores were collected by gentle washing of the mycelium with 10 ml of Dulbecco’s phosphate-buffered saline (PBS) (Sigma-Aldrich, Irvine, United Kingdom). The spore suspension was washed with PBS, and spore numbers were enumerated using a hemocytometer. For visualization purposes, 108 spores were stained with 100 μg/ml Fluorescent brightener 28 (Sigma-Aldrich, Irvine, United Kingdom), washed with PBS, and resuspended in 1 ml of 10% polyvinylpyrrolidone (PVP) (40 kDa; Sigma-Aldrich, Irvine, United Kingdom) with 0.05% phenol red as an injection marker as previously described (17).
Hindbrain ventricle injection.
Hindbrain injections were conducted as previously described (17, 51). Briefly, the developmental stage of zebrafish embryos was assessed according to Kimmel et al. for injection at the prim-25 stage (52). Embryos were manually dechorionated and anesthetized with 160 μg/ml ethyl 3-aminobenzoate methanesulfonate salt (tricaine; Sigma-Aldrich, Irvine, United Kingdom). Transgenic embryos were screened and selected for expression of the cell-specific fluorescent label prior to injection. Infection doses of 100 sporangiospores per fish were achieved by microinjecting 2 nl of a 108-spore/ml suspension in 10% PVP through the otic vesicle into the hindbrain ventricle of the zebrafish embryo; 2 nl of PVP was injected as a control. The carrier medium PVP was chosen due to its increased density, enabling increased injection consistency and reduced clogging of microinjection needles. Infection dose and location were confirmed microscopically immediately after microinjection. Larvae were kept in 200 μl of E3 in individual wells of 96-well plates with or without chemical manipulation. Larvae were monitored every 24 h for phagocyte numbers/recruitment, granuloma formation, hyphal growth, dissemination, and spore and larval survival up to 5 dpf. At 5 dpf, larvae were sacrificed with a tricaine overdose (10×).
Chemical treatments.
Immune suppression was mimicked by treatment with the steroid drug dexamethasone (Dex) (14, 17). Larvae were immersed in E3 with 40 μg/ml water-soluble dexamethasone (Sigma-Aldrich, Irvine, United Kingdom) 4 h prior to microinjection of spores and maintained in dexamethasone-containing E3 for survival and phagocyte recruitment studies. For reactivation studies, larvae were transferred from E3 to E3 containing dexamethasone after formation of innate granulomas.
Spore viability assessment.
Spore viability was assessed as previously described (17). Briefly, after microinjection of fungal spores, larvae were individually euthanized with a 10× overdose of tricaine and homogenized in 100 μl penicillin-streptomycin (10,000 U/ml penicillin and 10 mg/ml streptomycin; Sigma-Aldrich, Irvine, United Kingdom) and plated onto SAB agar plates with 100 U/ml penicillin, 100 μg/ml streptomycin, and 30 μg/ml gentamicin (Sigma-Aldrich, Irvine, United Kingdom). Plates were incubated at room temperature for 24 to 48 h before CFU were counted.
Fluorescence microscopy.
For microscopic analysis, individually kept zebrafish embryos were anesthetized with 200 μg/ml tricaine in E3 in 96-well plates. Phagocyte numbers at the site of infection and in the whole embryos, innate granuloma formation, spore dissemination, and fungal filamentous growth within infected embryos was assessed through a Zeiss Axio observer Z1 microscope with an ApoTome system (Zeiss, Cambridge, United Kingdom) using objective lenses with powers of 10×/0.25 numerical aperture (NA), 20×/0.4 NA, and 40×/0.6 NA (Zeiss, Cambridge, United Kingdom). Green fluorescent protein, mCherry, and fluorescent brightener fluorescent signals were detected by their emission signals at 509 nm (excitation, 488 nm), 610 nm (excitation, 587 nm), and 465 nm (excitation, 353 nm), respectively. Images were taken and processed with the open community platform for BioImage informatics Icy (53), and figures were compiled in Illustrator C3 (Adobe Systems, San Jose, CA, United States). For cell tracking analysis, movies were analyzed using Volocity software (Improvision, Coventry, United Kingdom) to determine the mean fluorescence intensity of mCherry (macrophages) or GFP (neutrophils) across the field of view at each time point over the 12-h imaging period, and data were normalized to the first frame. Innate granuloma formation was defined as accumulation of >10 phagocytes in a 40- by 40-μm area. A spore dissemination event was recorded if there was at least one spore that was observed outside the hindbrain ventricle compartment (17).
Measurement of reactive oxygen species production.
In order to evaluate the reactive oxygen burst induced in response to infection with fungal spores, the oxidative stress indicator chloromethyl derivative 5-(and-6)-chloromethyl-2′,7′-dichlorohydrofluorescein diacetate (CM-H2DCFDA; Invitrogen, Fisher Scientific, Loughborough, United Kingdom) was used to measure reactive oxygen species (ROS). Infected larvae were incubated in pairs in E3 containing 5 mM of CM-H2DCFDA in 96-well plates, and ROS production was measured as fluorescence from CM-H2DCFDA upon oxidation by ROS. Fluorescence was measured at 520 nm (excitation, 485 to 12 nm) with the FLUOstar Omega microplate reader (BMG Labtech, Aylesbury, United Kingdom). One hundred nanograms per milliliter phorbol 12-myristate 13-acetate (PMA; Sigma-Aldrich, Irvine, United Kingdom) was used as a positive control. Wells with dead fish were excluded from the analysis.
qRT-PCR.
One hour after injections of PVP or fungal spores into control or dexamethasone-treated larvae, 15 fish were placed in Eppendorf tubes, euthanized with an overdose of tricaine, and homogenized. Total RNA was isolated from homogenates using the PureLink RNA minikit (Thermo, Fisher Scientific) according to the manufacturer’s instructions and reverse transcribed into cDNA using the using iScript cDNA synthesis kit (Bio-Rad). Quantitative reverse transcription-PCR (qRT-PCR) was performed using the Brilliant III Ultra-Fast SYBR green (Agilent) for arp (housekeeping gene) with forward primer 5′ CTGCAAAGATGCCCAGGGA 3′ and reverse primer 5′ TTGGAGCCGACATTGTCTGC 3′, tnf-α with forward primer 5′ TCGCATTTCACAAGGCAATTT 3′ and reverse primer 5′ GGCCTGGTCCTGGTCATCTC 3′, and il-8 with forward primer 5′ GTCGCTGCATTGAAACAGAA 3′ and reverse primer 5′ CTTAACCCATGGAGCAGAGG 3′ (Eurofins Scientific). Amplification was performed with the Aria Mx (Agilent) thermocycler and the following conditions: 10 min of denaturation at 95°C, followed by 40 cycles of 15 s at 95°C and 1 min at 60°C. A final dissociation curve was performed for each group. Threshold cycles (CT) and dissociation curves were analyzed with the Aria MX software package. Gene expression levels were normalized to zebrafish arp (ΔCT) and compared with PVP-injected controls (ΔΔCT). Results are presented as fold change (2ΔΔCT) (17, 54).
Data analysis and statistics.
Data were collected from at least three independent experimental repeats. Exact numbers of experimental repeats and embryos investigated are given where indicated in the Results section. Data were analyzed with GraphPad Prism version 7.0a software (GraphPad, La Jolla, CA). The statistical analysis methods for the different data sets are specified in the Results section and figure legends. P values of <0.05 were considered statistically significant and are indicated in the figures as follows: *, P < 0.05; **, P < 0.01; and ***, P < 0.001.
Mathematical model formulation.
We developed an ordinary differential equation (ODE) model of the early stages of a mucormycosis infection to explore immunomodulation effects. Related ODE models of immunomodulation include applications to bacterial infections (55), HIV (56), and oncolysis (57), while an agent-based model is used to explore diverse movement strategies of neutrophils toward fungal spores in the study by Tokarski et al. (58).
Our mucormycosis infection model consists of four interacting components (Fig. 3A and B): the population (at the site of infection) of infectious fungal spores (S), the hyphae produced by spore germination (H), and the available pools of macrophages (M) and neutrophils (N). (Both are recruited to the infection via the presence of spores and inhibit formation of hyphae.) In brief, we use mass action kinetics, including saturation terms where necessary (in particular we square the numbers of macrophages and neutrophils on the denominator of equations 3 and 4 from panel B following a model selection process in which this was found to improve the model fit to the data), making the assumption that the system is well mixed and spatial dependencies can be ignored. To generate the model, events were assumed to occur as described below. Infectious spores initiate events and form hyphae at rate rH. Macrophages are recruited to the infection site through the presence of spores at rate rM. Based on results that neutrophils are delayed from arriving at the site of infection relative to macrophages (see Results and Fig. 1D and E), neutrophils are assumed to be recruited in response to the presence of macrophages at rate rN. At the site of infection, we assume that there are maximum numbers of macrophages and neutrophils (KM and KN, respectively) that are recruited (akin to the carrying capacity widely used in modeling in microbiology). KM and KN are fixed parameters that we vary between simulations to mimic zebrafish with different immune response strengths. Macrophages and neutrophils act independently to inhibit hyphae formation described by the rates βM and βN, respectively, but they do not kill Mucorales (see Results and Fig. 5A). Death of immune cells is negligible over the time course of interest. We note that we have investigated the possibility that hyphae also attract macrophages to the infection site, but as hyphae formation is generally established as the phagocytes are approaching carrying capacity, this had no qualitative effect on our results; we therefore omit this possibility for simplicity.
Mathematical model parameterization.
Initial numbers of macrophages, neutrophils, and hyphae at the site of the infection were set to 0 based on in vivo observations, while the initial number of spores was 100 (as per the experimental protocol). Parameterization was performed by minimizing an appropriate objective function using fminsearch in MATLAB. Estimates of the recruitment rates rM and rN were based on the time series raw data of the recruitment in vivo assays (see Results and Fig. 1D and E; with objective function the sum of the l2-norm of the model errors for macrophage and neutrophil count using a reduced model for phagocyte recruitment only). Note that though the units are different between these data and the variables in the model (and there is currently no obvious means to convert between the two), we have used the data to obtain information about the relative sizes of these two parameters. To address this uncertainty, these (and indeed all) parameters are subject to sensitivity analyses performed later in the study.
KM and KN are assumed to vary between zebrafish and were taken as the number of macrophages and neutrophils, respectively, at the infection site after 24 h (see Table S1 in the supplemental material) as experimental observations indicate phagocyte numbers have saturated by this time point. The full model was simulated against these data, and the objective function was used to estimate the remaining parameters. The objective function is given by the l2-norm of the vector, vi, where for i = 1 … 16 (deceased fish [Table S1A])
with and , the simulated and recorded death times, respectively. (Note that a fish may have died at any point in the 24 h preceding the recorded death time.) For i = 17 … 36 (fish surviving to 120 h [Table S1B]), .
To calculate a simulated time of death, it is assumed that hyphae amass until they reach a critical value, termed H*, at which point host damage is correspondent with death. (H* must also be estimated as part of the parameterization process.) Latin hypercube sampling was used to generate a range of starting guesses (fminsearch is a local optimizer). We subsequently explored a range of promising parameter sets that gave equivalent qualitative results throughout. We present only one of these here (that which gave the lowest obtained objective function value): rM = 0.013 (h−1), rN = 0.033 (h−1), rH = 2.32 (h−1), βM = 1.30 (fungal cells)(immune cells)−1, βN = 1.02 (fungal cells)(immune cells)−1, H* = 58.85 (fungal cells), and KH = 1.12 (fungal cells), with KN and KM taken for each zebrafish from Table S1A and B. Results of this parameterization are given in Fig. S3A and B in the supplemental material. We note that where required fold changes in parameters for specific outputs are stated in Results, these are given for comparison purposes between cases investigated within one parameter set and may differ for alternative parameter sets (while remaining qualitatively equivalent).
Ethics statement.
All zebrafish care and experiments were conducted according to Home Office legislation and the Animals (Scientific Procedures) Act 1986 (ASPA) under Home Office project license 40/3681 and personal licenses l13220C2C to Kerstin Voelz and l9EE992EF to Aleksandra Jasiulewicz.
ACKNOWLEDGMENTS
This work was supported by a Wellcome Trust Seed award to K.V. (108387/Z/15/Z). S.I. is funded by the Wellcome Trust 4-year studentship program in mechanisms of inflammatory disease (MIDAS; 108871). S.J. gratefully acknowledges support from the Biotechnology and Biological Sciences Research Council (BB/M021386/1) and the Wellcome Trust (grant code 1516ISSFFEL9) for funding a parameterization workshop at the University of Birmingham (United Kingdom). M.H., J.T., and G.Y. are supported by an Engineering and Physical Sciences Doctoral Training Partnership award (EP/M508202/1 and EP/N509590/1). S.M. is supported by a Wellcome Trust Research Career Development fellowship (WT097411MA) and the Lister Institute of Preventive Medicine.
We also thank Elizabeth Ballou for critical input while preparing the manuscript.
S.I. performed the in silico modeling and wrote the manuscript. A.J. performed the experiments and data analysis. O.R.M. conducted the cell tracking analysis and commented on the manuscript. S.M. supported the ROS experiments and commented on the manuscript. M.H., J.T., and G.Y. performed the model parameterization. S.J. performed the in silico modeling, wrote the manuscript, and oversaw the modeling work. K.V. conceived the work, conducted the data analysis, and wrote the manuscript.
Footnotes
Citation Inglesfield S, Jasiulewicz A, Hopwood M, Tyrrell J, Youlden G, Mazon-Moya M, Millington OR, Mostowy S, Jabbari S, Voelz K. 2018. Robust phagocyte recruitment controls the opportunistic fungal pathogen Mucor circinelloides in innate granulomas in vivo. mBio 9:e02010-17. https://doi.org/10.1128/mBio.02010-17.
REFERENCES
- 1.Ibrahim AS, Spellberg B, Walsh TJ, Kontoyiannis DP. 2012. Pathogenesis of mucormycosis. Clin Infect Dis 54(Suppl 1):S16–S22. doi: 10.1093/cid/cir865. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Frater JL, Hall GS, Procop GW. 2001. Histologic features of zygomycosis: emphasis on perineural invasion and fungal morphology. Arch Pathol Lab Med 125:375–378. http://www.archivesofpathology.org/doi/full/10.1043/0003-9985%282001%29125%3C0375%3AHFOZ%3E2.0.CO%3B2?=. [DOI] [PubMed] [Google Scholar]
- 3.Spellberg B, Edwards J Jr, Ibrahim A. 2005. Novel perspectives on mucormycosis: pathophysiology, presentation, and management. Clin Microbiol Rev 18:556–569. doi: 10.1128/CMR.18.3.556-569.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Smith JM. 1976. In vivo development of spores of Absidia ramosa. Sabouraudia 14:11–15. doi: 10.1080/00362177685190041. [DOI] [PubMed] [Google Scholar]
- 5.Petrikkos G, Skiada A, Lortholary O, Roilides E, Walsh TJ, Kontoyiannis DP. 2012. Epidemiology and clinical manifestations of mucormycosis. Clin Infect Dis 54(Suppl 1):S23–S34. doi: 10.1093/cid/cir866. [DOI] [PubMed] [Google Scholar]
- 6.Brown GD, Denning DW, Gow NA, Levitz SM, Netea MG, White TC. 2012. Hidden killers: human fungal infections. Sci Transl Med 4:165rv13. doi: 10.1126/scitranslmed.3004404. [DOI] [PubMed] [Google Scholar]
- 7.Bitar D, Lortholary O, Le Strat Y, Nicolau J, Coignard B, Tattevin P, Che D, Dromer F. 2014. Population-based analysis of invasive fungal infections, France, 2001–2010. Emerg Infect Dis 20:1149–1155. doi: 10.3201/eid2007.140087. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Ibrahim AS, Edwards JE Jr, Bryant R, Spellberg B. 2009. Economic burden of mucormycosis in the United States: can a vaccine be cost-effective? Med Mycol 47:592–600. doi: 10.1080/13693780802326001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Chayakulkeeree M, Ghannoum MA, Perfect JR. 2006. Zygomycosis: the re-emerging fungal infection. Eur J Clin Microbiol Infect Dis 25:215–229. doi: 10.1007/s10096-006-0107-1. [DOI] [PubMed] [Google Scholar]
- 10.Ribes JA, Vanover-Sams CL, Baker DJ. 2000. Zygomycetes in human disease. Clin Microbiol Rev 13:236–301. doi: 10.1128/CMR.13.2.236-301.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Waldorf AR. 1989. Pulmonary defense mechanisms against opportunistic fungal pathogens. Immunol Ser 47:243–271. [PubMed] [Google Scholar]
- 12.Levitz SM, Selsted ME, Ganz T, Lehrer RI, Diamond RD. 1986. In vitro killing of spores and hyphae of Aspergillus fumigatus and Rhizopus oryzae by rabbit neutrophil cationic peptides and bronchoalveolar macrophages. J Infect Dis 154:483–489. doi: 10.1093/infdis/154.3.483. [DOI] [PubMed] [Google Scholar]
- 13.Kamei K. 2001. Animal models of zygomycosis—Absidia, Rhizopus, Rhizomucor, and Cunninghamella. Mycopathologia 152:5–13. [DOI] [PubMed] [Google Scholar]
- 14.Chamilos G, Lewis RE, Hu J, Xiao L, Zal T, Gilliet M, Halder G, Kontoyiannis DP. 2008. Drosophila melanogaster as a model host to dissect the immunopathogenesis of zygomycosis. Proc Natl Acad Sci U S A 105:9367–9372. doi: 10.1073/pnas.0709578105. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Waldorf AR, Levitz SM, Diamond RD. 1984. In vivo bronchoalveolar macrophage defense against Rhizopus oryzae and Aspergillus fumigatus. J Infect Dis 150:752–760. doi: 10.1093/infdis/150.5.752. [DOI] [PubMed] [Google Scholar]
- 16.Jorens PG, Boelaert JR, Halloy V, Zamora R, Schneider YJ, Herman AG. 1995. Human and rat macrophages mediate fungistatic activity against Rhizopus species differently: in vitro and ex vivo studies. Infect Immun 63:4489–4494. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Voelz K, Gratacap RL, Wheeler RT. 2015. A zebrafish larval model reveals early tissue-specific innate immune responses to Mucor circinelloides. Dis Model Mech 8:1375–1388. doi: 10.1242/dmm.019992. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Waldorf AR, Ruderman N, Diamond RD. 1984. Specific susceptibility to mucormycosis in murine diabetes and bronchoalveolar macrophage defense against Rhizopus. J Clin Invest 74:150–160. doi: 10.1172/JCI111395. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Chamilos G, Lionakis MS, Lewis RE, Lopez-Ribot JL, Saville SP, Albert ND, Halder G, Kontoyiannis DP. 2006. Drosophila melanogaster as a facile model for large-scale studies of virulence mechanisms and antifungal drug efficacy in Candida species. J Infect Dis 193:1014–1022. doi: 10.1086/500950. [DOI] [PubMed] [Google Scholar]
- 20.Diamond RD. 1983. Inhibition of monocyte-mediated damage to fungal hyphae by steroid hormones. J Infect Dis 147:160. doi: 10.1093/infdis/147.1.160. [DOI] [PubMed] [Google Scholar]
- 21.Kontoyiannis DP, Lionakis MS, Lewis RE, Chamilos G, Healy M, Perego C, Safdar A, Kantarjian H, Champlin R, Walsh TJ, Raad II. 2005. Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases. J Infect Dis 191:1350–1360. doi: 10.1086/428780. [DOI] [PubMed] [Google Scholar]
- 22.Diamond RD, Haudenschild CC, Erickson NF III. 1982. Monocyte-mediated damage to Rhizopus oryzae hyphae in vitro. Infect Immun 38:292–297. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Diamond RD, Krzesicki R, Epstein B, Jao W. 1978. Damage to hyphal forms of fungi by human leukocytes in vitro. A possible host defense mechanism in aspergillosis and mucormycosis. Am J Pathol 91:313–328. [PMC free article] [PubMed] [Google Scholar]
- 24.Diamond RD, Clark RA. 1982. Damage to Aspergillus fumigatus and Rhizopus oryzae hyphae by oxidative and nonoxidative microbicidal products of human neutrophils in vitro. Infect Immun 38:487–495. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Fang FC. 2011. Antimicrobial actions of reactive oxygen species. mBio 2:e00141-11. doi: 10.1128/mBio.00141-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Wu SY, Huang JH, Chen WY, Chan YC, Lin CH, Chen YC, Liu FT, Wu-Hsieh BA. 2017. Cell intrinsic galectin-3 attenuates neutrophil ROS-dependent killing of Candida by modulating CR3 downstream Syk activation. Front Immunol 8:48. doi: 10.3389/fimmu.2017.00048. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Davis JM, Clay H, Lewis JL, Ghori N, Herbomel P, Ramakrishnan L. 2002. Real-time visualization of mycobacterium-macrophage interactions leading to initiation of granuloma formation in zebrafish embryos. Immunity 17:693–702. doi: 10.1016/S1074-7613(02)00475-2. [DOI] [PubMed] [Google Scholar]
- 28.Dubey A, Patwardhan RV, Sampth S, Santosh V, Kolluri S, Nanda A. 2005. Intracranial fungal granuloma: analysis of 40 patients and review of the literature. Surg Neurol 63:254–260. doi: 10.1016/j.surneu.2004.04.020. [DOI] [PubMed] [Google Scholar]
- 29.Avelar-Pires C, Simoes-Quaresma JA, Moraes-de Macedo GM, Brasil-Xavier M, Cardoso-de Brito A. 2013. Revisiting the clinical and histopathological aspects of patients with chromoblastomycosis from the Brazilian Amazon region. Arch Med Res 44:302–306. doi: 10.1016/j.arcmed.2013.04.008. [DOI] [PubMed] [Google Scholar]
- 30.Zumla A, James DG. 1996. Granulomatous infections: etiology and classification. Clin Infect Dis 23:146–158. doi: 10.1093/clinids/23.1.146. [DOI] [PubMed] [Google Scholar]
- 31.Davis JM, Ramakrishnan L. 2009. The role of the granuloma in expansion and dissemination of early tuberculous infection. Cell 136:37–49. doi: 10.1016/j.cell.2008.11.014. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Clay H, Davis JM, Beery D, Huttenlocher A, Lyons SE, Ramakrishnan L. 2007. Dichotomous role of the macrophage in early Mycobacterium marinum infection of the zebrafish. Cell Host Microbe 2:29–39. doi: 10.1016/j.chom.2007.06.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Feldmesser M, Kress Y, Novikoff P, Casadevall A. 2000. Cryptococcus neoformans is a facultative intracellular pathogen in murine pulmonary infection. Infect Immun 68:4225–4237. doi: 10.1128/IAI.68.7.4225-4237.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Richardson MD, Smith H. 1981. Resistance of virulent and attenuated strains of Candida albicans to intracellular killing by human and mouse phagocytes. J Infect Dis 144:557–564. doi: 10.1093/infdis/144.6.557. [DOI] [PubMed] [Google Scholar]
- 35.Li CH, Cervantes M, Springer DJ, Boekhout T, Ruiz-Vazquez RM, Torres-Martinez SR, Heitman J, Lee SC. 2011. Sporangiospore size dimorphism is linked to virulence of Mucor circinelloides. PLoS Pathog 7:e1002086. doi: 10.1371/journal.ppat.1002086. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Charlier C, Nielsen K, Daou S, Brigitte M, Chretien F, Dromer F. 2009. Evidence of a role for monocytes in dissemination and brain invasion by Cryptococcus neoformans. Infect Immun 77:120–127. doi: 10.1128/IAI.01065-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Tedder M, Spratt JA, Anstadt MP, Hegde SS, Tedder SD, Lowe JE. 1994. Pulmonary mucormycosis: results of medical and surgical therapy. Ann Thorac Surg 57:1044–1050. doi: 10.1016/0003-4975(94)90243-7. [DOI] [PubMed] [Google Scholar]
- 38.Gleissner B, Schilling A, Anagnostopolous I, Siehl I, Thiel E. 2004. Improved outcome of zygomycosis in patients with hematological diseases? Leuk Lymphoma 45:1351–1360. doi: 10.1080/10428190310001653691. [DOI] [PubMed] [Google Scholar]
- 39.Sheldon WH, Bauer H. 1958. Activation of quiescent mucormycotic granulomata in rabbits by induction of acute alloxan diabetes. J Exp Med 108:171–178. doi: 10.1084/jem.108.1.171. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Sheldon WH, Bauer H. 1959. The development of the acute inflammatory response to experimental cutaneous mucormycosis in normal and diabetic rabbits. J Exp Med 110:845–852. doi: 10.1084/jem.110.6.845. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Waldorf AR, Diamond RD. 1984. Cerebral mucormycosis in diabetic mice after intrasinus challenge. Infect Immun 44:194–195. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Corbel MJ, Eades SM. 1978. Observations on the localization of Absidia corymbifera in vivo. Sabouraudia 16:125–132. doi: 10.1080/00362177885380181. [DOI] [PubMed] [Google Scholar]
- 43.Waldorf AR, Peter L, Polak A. 1984. Mucormycotic infection in mice following prolonged incubation of spores in vivo and the role of spore agglutinating antibodies on spore germination. Sabouraudia 22:101–108. doi: 10.1080/00362178485380171. [DOI] [PubMed] [Google Scholar]
- 44.Ibrahim AS, Kontoyiannis DP. 2013. Update on mucormycosis pathogenesis. Curr Opin Infect Dis 26:508–515. doi: 10.1097/QCO.0000000000000008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Chamilos G, Ganguly D, Lande R, Gregorio J, Meller S, Goldman WE, Gilliet M, Kontoyiannis DP. 2010. Generation of IL-23 producing dendritic cells (DCs) by airborne fungi regulates fungal pathogenicity via the induction of T(H)-17 responses. PLoS One 5:e12955. doi: 10.1371/journal.pone.0012955. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Potenza L, Vallerini D, Barozzi P, Riva G, Forghieri F, Zanetti E, Quadrelli C, Candoni A, Maertens J, Rossi G, Morselli M, Codeluppi M, Paolini A, Maccaferri M, Del Giovane C, D’Amico R, Rumpianesi F, Pecorari M, Cavalleri F, Marasca R, Narni F, Luppi M. 2011. Mucorales-specific T cells emerge in the course of invasive mucormycosis and may be used as a surrogate diagnostic marker in high-risk patients. Blood 118:5416–5419. doi: 10.1182/blood-2011-07-366526. [DOI] [PubMed] [Google Scholar]
- 47.Wurster S, Thielen V, Weis P, Walther P, Elias J, Waaga-Gasser AM, Dragan M, Dandekar T, Einsele H, Löffler J, Ullmann AJ. 2017. Mucorales spores induce a proinflammatory cytokine response in human mononuclear phagocytes and harbor no rodlet hydrophobins. Virulence 8:1708–1718. doi: 10.1080/21505594.2017.1342920. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Renshaw SA, Loynes CA, Trushell DM, Elworthy S, Ingham PW, Whyte MK. 2006. A transgenic zebrafish model of neutrophilic inflammation. Blood 108:3976–3978. doi: 10.1182/blood-2006-05-024075. [DOI] [PubMed] [Google Scholar]
- 49.Ellett F, Pase L, Hayman JW, Andrianopoulos A, Lieschke GJ. 2011. mpeg1 promoter transgenes direct macrophage-lineage expression in zebrafish. Blood 117:e49–e56. doi: 10.1182/blood-2010-10-314120. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Westerfield M. 2000. The zebrafish book. University Press Oregon, Eugene, OR. [Google Scholar]
- 51.Brothers KM, Newman ZR, Wheeler RT. 2011. Live imaging of disseminated candidiasis in zebrafish reveals role of phagocyte oxidase in limiting filamentous growth. Eukaryot Cell 10:932–944. doi: 10.1128/EC.05005-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Kimmel CB, Ballard WW, Kimmel SR, Ullmann B, Schilling TF. 1995. Stages of embryonic development of the zebrafish. Dev Dyn 203:253–310. doi: 10.1002/aja.1002030302. [DOI] [PubMed] [Google Scholar]
- 53.de Chaumont F, Dallongeville S, Chenouard N, Hervé N, Pop S, Provoost T, Meas-Yedid V, Pankajakshan P, Lecomte T, Le Montagner Y, Lagache T, Dufour A, Olivo-Marin JC. 2012. Icy: an open Bioimage informatics platform for extended reproducible research. Nat Methods 9:690–696. doi: 10.1038/nmeth.2075. [DOI] [PubMed] [Google Scholar]
- 54.Gratacap RL, Rawls JF, Wheeler RT. 2013. Mucosal candidiasis elicits NF-κB activation, proinflammatory gene expression and localized neutrophilia in zebrafish. Dis Model Mech 6:1260–1270. doi: 10.1242/dmm.012039. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Jarrett AM, Cogan NG, Hussaini MY. 2015. Mathematical model for MRSA nasal carriage. Bull Math Biol 77:1787–1812. doi: 10.1007/s11538-015-0104-6. [DOI] [PubMed] [Google Scholar]
- 56.Joly M, Odloak D, Rondó PHC. 2016. Human immunomodulation and initial HIV spread. Comput Chem Eng 84:255–280. doi: 10.1016/j.compchemeng.2015.09.004. [DOI] [Google Scholar]
- 57.Kim PS, Crivelli JJ, Choi IK, Yun CO, Wares JR. 2015. Quantitative impact of immunomodulation versus oncolysis with cytokine-expressing virus therapeutics. Math Biosci Eng 12:841–858. doi: 10.3934/mbe.2015.12.841. [DOI] [PubMed] [Google Scholar]
- 58.Tokarski C, Hummert S, Mech F, Figge MT, Germerodt S, Schroeter A, Schuster S. 2012. Agent-based modeling approach of immune defense against spores of opportunistic human pathogenic fungi. Front Microbiol 3:129. doi: 10.3389/fmicb.2012.00129. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.